NCT00005623View on ClinicalTrials.gov

Cyproterone Acetate in Treating Hot Flashes Following Surgical or Chemical Castration for Prostate Cancer

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 1999

Study Completion Date

January 31, 2004

Conditions
Hot FlashesProstate Cancer
Interventions
DRUG

cyproterone acetate

PROCEDURE

quality-of-life assessment

Trial Locations (1)

10970-0519

Barr Laboratories, Incorporated, Pomona

Sponsors

Lead Sponsor

Barr Laboratories
All Listed Sponsors
lead

Barr Laboratories

INDUSTRY

NCT00005623 - Cyproterone Acetate in Treating Hot Flashes Following Surgical or Chemical Castration for Prostate Cancer | Biotech Hunter | Biotech Hunter